Oragenics, Inc. announced that Effective December 15, 2022, Ms. Kimberly Murphy, the companyâs President and Chief Executive Officer, was appointed Interim Chief Financial Officer, Secretary and Treasurer of the company to serve while the Company conducts its search process to identity and appoint a new Chief Financial Officer. In addition, Mr. Sullivan has agreed to remain available to the Company as a consultant for a limited amount of time commencing December 15, 2022 through January 31, 2023 to continue to assist the Company with transition matters. The company previously reported Michael Sullivanâs resignation as Chief Financial Officer, Secretary and Treasurer of the Company, to be effective December 14, 2022, and the Companyâs commencement of a search for his replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 USD | +31.76% | +104.67% | -45.43% |
May. 16 | Sector Update: Health Care Stocks Ease Thursday Afternoon | MT |
May. 16 | Oragenics to Start Phase 2 Concussion Treatment Drug Trial -- Shares Rise | MT |
1st Jan change | Capi. | |
---|---|---|
-45.43% | 13.76M | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.26% | 21.6B | |
-12.38% | 22.31B | |
-5.71% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- OGEN Stock
- News Oragenics, Inc.
- Oragenics, Inc. Appoints Kimberly Murphy as Secretary and Treasurer